Weekly Pulse: Single-Payer Bills Pass Vermont Senate, House

Lindsay Beyerstein

The Vermont state Senate passed legislation to create a single-payer health insurance system, Paul Waldman reports for TAPPED. Since the state House has already passed a similar bill, all that's left to do is reconcile the two pieces of legislation before the governor signs it into law. Waldman stresses that there are still many details to work out, including how the system will be funded. Vermont might end up with a system like France's where everyone has basic public insurance, which most people supplement with additional private coverage. The most important thing, Waldman argues, is that Vermont is moving to sever the link between employment and health insurance. Roe showdown Anti-choicers are gunning for a Roe v. Wade showdown in the Supreme Court before Obama can appoint any more justices. At the behest of an unnamed conservative group, Republican state Rep. John LaBruzzo of Louisiana has introduced a bill that would ban all abortions, even to save the woman's life. The original bill upped the anti-choice ante by criminalizing not only doctors who perform abortions, but also women who procure them. LaBruzzo has since promised to scale the bill back to just criminalizing doctors. This is all blatantly unconstitutional, of course, but as Kate Sheppard explains in Mother Jones, that's precisely the point: The Constitution, of course, is exactly what LaBruzzo is targeting. He admits his proposal is intended as a direct challenge to Roe v. Wade, the landmark 1973 case in which the Supreme Court ruled that the constitutional right to privacy included the right to abortions in some circumstances. LaBruzzo says he'd like his bill to become law and "immediately go to court," and he told a local paper that an unnamed conservative religious group asked him to propose the law for exactly that purpose. Drug pushers in your living room Martha Rosenberg poses a provocative question at AlterNet: Does anyone remember a time before "Ask Your Doctor" ads overran the airwaves, Internet, buses, billboards, and seemingly every other medium? Direct-to-consumer (DTC) drug advertising has become so ubiquitous that it's easy to forget that it was illegal until the late '90s. In the days before DTC, drug advertising was limited to medical journals, prescription pads, golf towels, and pill-shaped stress balls distributed in doctors' offices--which makes sense. The whole point of making a drug prescription-only is to put the decision-making power in the hands of doctors. Now, drug companies advertise to consumers for the same reason that food companies advertise to children. It's called "pester power." DTC drug ads encourage consumers to self-diagnose based on vague and sometimes nearly universal symptoms like poor sleep, daytime drowsiness, anxiety, and depression. Once consumers are convinced they're suffering from industry-hyped constructs like "erectile dysfunction" and "premenstrual dysphoric disorder," they're going to badger their doctors for prescriptions. That's not to say that these terms don't encompass legitimate health problems, but rather that DTC markets products in such vague terms that a lot of healthy people are sure to be clamoring for drugs they don't need. Typically, neither the patient nor the doctor is paying the full cost of the drug, so patients are more likely to ask and doctors have little incentive to say no. Greenwashing air fresheners A reader seeks the counsel of Grist's earthy advice columnist Umbra on the issue of air fresheners. Some of these odor-concealing aerosols are touting themselves as green for adopting all-natural propellants. Does that make them healthier, or greener? Only marginally, says Umbra. Air fresheners still contain formaldehyde, petroleum distillates, and other questionable chemicals. This post features links to the best independent, progressive reporting about health care by members of The Media Consortium. It is free to reprint. Visit the Pulse for a complete list of articles on health care reform, or follow us on Twitter. And for the best progressive reporting on critical economy, environment, health care and immigration issues, check out The Audit, The Mulch, and The Diaspora. This is a project of The Media Consortium, a network of leading independent media outlets.

Please consider supporting our work.

I hope you found this article important. Before you leave, I want to ask you to consider supporting our work with a donation. In These Times needs readers like you to help sustain our mission. We don’t depend on—or want—corporate advertising or deep-pocketed billionaires to fund our journalism. We’re supported by you, the reader, so we can focus on covering the issues that matter most to the progressive movement without fear or compromise.

Our work isn’t hidden behind a paywall because of people like you who support our journalism. We want to keep it that way. If you value the work we do and the movements we cover, please consider donating to In These Times.

Lindsay Beyerstein is an award-winning investigative journalist and In These Times staff writer who writes the blog Duly Noted. Her stories have appeared in Newsweek, Salon, Slate, The Nation, Ms. Magazine, and other publications. Her photographs have been published in the Wall Street Journal and the New York Times’ City Room. She also blogs at The Hillman Blog (http://​www​.hill​man​foun​da​tion​.org/​h​i​l​l​m​a​nblog), a publication of the Sidney Hillman Foundation, a non-profit that honors journalism in the public interest.
Illustrated cover of Gaza issue. Illustration shows an illustrated representation of Gaza, sohwing crowded buildings surrounded by a wall on three sides. Above the buildings is the sun, with light shining down. Above the sun is a white bird. Text below the city says: All Eyes on Gaza
Get 10 issues for $19.95

Subscribe to the print magazine.